Compounds > alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Adjuvant Arthritis

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Adjuvant Arthritis in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neugebauer, V1
Kornhuber, J1
Lücke, T1
Schaible, HG1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Adjuvant Arthritis

ArticleYear
The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurones.
    Neuroreport, 1993, Sep-10, Volume: 4, Issue:11

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analgesics; Animals; Arthritis, Experiment

1993